.
Topic: Hiv Drug
Premium
Experts explain new anti-HIV jabs ahead of rollout tomorrow
Lenacapavir is expected to have no major side effects, with eligible Kenyans set to receive at least four injectable Pre-Exposure Prophylaxis (PrEP) doses annually.
By Mercy Kahenda
2026-02-25 00:00:00
.
Latest Articles
Health & Science
2026-07-10 14:43:35
Health & Science
2026-07-10 13:19:09
Health & Science
2026-07-09 15:32:33
Health & Science
2026-07-09 13:35:55
The Standard Group Plc is a multi-media organization with investments in media
platforms spanning newspaper print
operations, television, radio broadcasting, digital and online services. The
Standard Group is recognized as a
leading multi-media house in Kenya with a key influence in matters of national
and international interest.